![Simon Kerry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Simon Kerry
Chief Executive Officer at Karus Therapeutics Ltd.
Simon Kerry active positions
Companies | Position | Start | End |
---|---|---|---|
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 2005-12-31 | - |
Chief Executive Officer | 2005-12-31 | - | |
Argonaut Therapeutics Ltd.
![]() Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Chairman | - | - |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 2017-06-30 | - |
Curve Therapeutics Ltd.
![]() Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 2019-06-30 | - |
Founder | 2019-06-30 | - |
Career history of Simon Kerry
Former positions of Simon Kerry
Companies | Position | Start | End |
---|---|---|---|
Health Protection Agency | Corporate Officer/Principal | - | - |
Actigen Ltd.
![]() Actigen Ltd. BiotechnologyHealth Technology Actigen Ltd. provides biological products. The private company is based in Cambridge, UK. | Corporate Officer/Principal | - | - |
Actinova Ltd.
![]() Actinova Ltd. Pharmaceuticals: MajorHealth Technology Part of Active Biotech AB, Actinova Ltd. is a British company that provides research and development services to the biotechnology sectors and also develops drugs and vaccines. The company is based in Cambridge, UK. | Corporate Officer/Principal | - | - |
Isogenica Ltd.
![]() Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Founder | - | - |
Corporate Officer/Principal | - | - | |
ACTIVE BIOTECH AB | Corporate Officer/Principal | - | - |
░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Simon Kerry
Loughborough University | Doctorate Degree |
Statistics
International
United Kingdom | 10 |
Sweden | 2 |
Belgium | 2 |
Operational
Corporate Officer/Principal | 6 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoral
Health Technology | 7 |
Commercial Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ACTIVE BIOTECH AB | Health Technology |
Private companies | 9 |
---|---|
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Ablynx NV
![]() Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Health Protection Agency | Government |
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Isogenica Ltd.
![]() Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
Actinova Ltd.
![]() Actinova Ltd. Pharmaceuticals: MajorHealth Technology Part of Active Biotech AB, Actinova Ltd. is a British company that provides research and development services to the biotechnology sectors and also develops drugs and vaccines. The company is based in Cambridge, UK. | Health Technology |
Actigen Ltd.
![]() Actigen Ltd. BiotechnologyHealth Technology Actigen Ltd. provides biological products. The private company is based in Cambridge, UK. | Health Technology |
Argonaut Therapeutics Ltd.
![]() Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Health Technology |
Curve Therapeutics Ltd.
![]() Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Simon Kerry
- Experience